Clinical Science Research and Development Service; Cooperative Studies Scientific Evaluation Committee; Notice of Meeting, 22807-22808 [E9-11211]

Download as PDF Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Notices Dated: April 28, 2009. Rose M. Miller, Acting Director, Financial Accounting and Services Division, Financial Management Service. [FR Doc. E9–11252 Filed 5–13–09; 8:45 am] BILLING CODE 4810–35–M DEPARTMENT OF THE TREASURY Office of Foreign Assets Control Unblocking of Specially Designated Nationals and Blocked Persons Pursuant to Executive Order 12978 AGENCY: Office of Foreign Assets Control, Treasury. ACTION: Notice. SUMMARY: The Treasury Department’s Office of Foreign Assets Control (‘‘OFAC’’) is publishing the names of four individuals whose property and interests in property have been unblocked pursuant to Executive Order 12978 of October 21, 1995, Blocking Assets and Prohibiting Transactions with Significant Narcotics Traffickers. DATES: The unblocking and removal from the list of Specially Designated Nationals and Blocked Persons (‘‘SDN List’’) of the four individuals identified in this notice whose property and interests in property were blocked pursuant to Executive Order 12978 of October 21, 1995, is effective on May 6, 2009. FOR FURTHER INFORMATION CONTACT: Assistant Director, Compliance Outreach & Implementation, Office of Foreign Assets Control, Department of the Treasury, Washington, DC 20220, tel.: 202/622–2420. SUPPLEMENTARY INFORMATION: Electronic and Facsimile Availability This document and additional information concerning OFAC are available from OFAC’s Web site (https://www.treas.gov/ofac) via facsimile through a 24-hour fax-ondemand service, tel.: (202) 622–0077. pwalker on PROD1PC71 with NOTICES Background On October 21, 1995, the President, invoking the authority, inter alia, of the International Emergency Economic Powers Act (50 U.S.C. 1701–1706) (‘‘IEEPA’’), issued Executive Order 12978 (60 FR 54579, October 24, 1995) (the ‘‘Order’’). In the Order, the President declared a national emergency to deal with the threat posed by significant foreign narcotics traffickers centered in Colombia and the harm that they cause in the United States and abroad. VerDate Nov<24>2008 17:37 May 13, 2009 Jkt 217001 Section 1 of the Order blocks, with certain exceptions, all property and interests in property that are in the United States, or that hereafter come within the United States or that are or hereafter come within the possession or control of United States persons, of: (1) The persons listed in an Annex to the Order; (2) any foreign person determined by the Secretary of Treasury, in consultation with the Attorney General and Secretary of State: (a) To play a significant role in international narcotics trafficking centered in Colombia; or (b) to materially assist in, or provide financial or technological support for or goods or services in support of, the narcotics trafficking activities of persons designated in or pursuant to the Order; and (3) persons determined by the Secretary of the Treasury, in consultation with the Attorney General and the Secretary of State, to be owned or controlled by, or to act for or on behalf of, persons designated pursuant to the Order. On May 6, 2009, the Acting Director of OFAC removed from the SDN List the four individuals listed below, whose property and interests in property were blocked pursuant to the Order. The listing of the four unblocked individuals follows: COLLAZOS TELLO, Jairo Camilo, c/o AGROPECUARIA LINDARAJA S.A., Cali, Colombia; c/o INVERSIONES BRASILAR S.A., Bogota, Colombia; c/o DIMABE LTDA., Bogota, Colombia; DOB 09 Dec 1953; POB Cali, Colombia; Cedula No. 14998261 (Colombia); Passport AH690431 Colombia) (individual) [SDNT] DURAN ABDELNUR, Jorge Eduardo, c/o DURATEX S.A., Bogota, Colombia; c/o COMERCIALIZADORA MORDUR S.A., Quito, Ecuador; DOB 21 Nov 1955; POB Colombia; Cedula No. 19309441 (Colombia) (individual) [SDNT] RODRIGUEZ BALANTA, Jorge Enrique, c/o DISTRIBUCIONES GLOMIL LTDA., Cali, Colombia; c/o DISTRIBUIDORA MIGIL CALI S.A., Cali, Colombia; c/o DISMERCOOP, Cali, Colombia; DOB 24 Jun 1956; Cedula No. 16602232 (Colombia); Passport 16602232 (Colombia) (individual) [SDNT] GONZALEZ LIZALDA, Maria Lorena, c/o INVERSIONES Y CONSTRUCCIONES ATLAS LTDA., Cali, Colombia; DOB 20 Jul 1969; Cedula No. 31992548 (Colombia) (individual) [SDNT] PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 22807 Dated: May 6, 2009. Barbara Hammerle, Acting Director, Office of Foreign Assets Control. [FR Doc. E9–11205 Filed 5–13–09; 8:45 am] BILLING CODE 4811–45–P DEPARTMENT OF VETERANS AFFAIRS Clinical Science Research and Development Service; Cooperative Studies Scientific Evaluation Committee; Notice of Meeting The Department of Veterans Affairs (VA) gives notice under Public Law 92– 463 (Federal Advisory Committee Act) that a meeting of the Clinical Science Research and Development Service Cooperative Studies Scientific Evaluation Committee will be held on June 26, 2009, at The Ritz-Carlton, 1150 22nd Street, NW., Washington, DC. The meeting is scheduled to begin at 8 a.m. and end at 4 p.m. The Committee advises the Chief Research and Development Officer through the Director of the Clinical Science Research and Development Service on the relevance and feasibility of proposed projects and the scientific validity and propriety of technical details, including protection of human subjects. The session will be open to the public for approximately 30 minutes at the start of the meeting for the discussion of administrative matters and the general status of the program. The remaining portion of the meeting will be closed to the public for the Committee’s review, discussion and evaluation of research and development applications. During the closed portion of the meeting, discussions and recommendations will deal with qualifications of personnel conducting the studies, staff and consultant critiques of research proposals and similar documents and the medical records of patients who are study subjects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. As provided by section 10(d) of Public Law 92–463, as amended, closing portions of this meeting is in accordance with 5 U.S.C. 552b(c)(6) and (c)(9)(B). Those who plan to attend should contact Dr. Grant Huang, Deputy Director, Cooperative Studies Program (125), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, at (202) 461– 1700. Dated: May 6, 2009. E:\FR\FM\14MYN1.SGM 14MYN1 22808 Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Notices By Direction of the Secretary: E. Philip Riggin, Committee Management Officer. [FR Doc. E9–11211 Filed 5–13–09; 8:45 am] BILLING CODE 8320–01–P DEPARTMENT OF VETERANS AFFAIRS Advisory Committee on Disability Compensation; Notice of Meeting pwalker on PROD1PC71 with NOTICES The Department of Veterans Affairs (VA) gives notice under Public Law 92– 463 (Federal Advisory Committee Act) that the Advisory Committee on Disability Compensation will meet on June 1–2, 2009, at the St. Regis Washington DC, 923 16th and K Streets, NW., from 8:30 a.m. to 5 p.m. each day. The meeting will be held in the Carlton Room on June 1 and in the Chandelier Room on June 2. The meeting is open to the public. VerDate Nov<24>2008 17:37 May 13, 2009 Jkt 217001 The purpose of the Committee is to advise the Secretary of Veterans Affairs on the maintenance and periodic readjustment of the VA Schedule for Rating Disabilities. The Committee is to assemble and review relevant information relating to the nature and character of disabilities arising from service in the Armed Forces, provide an ongoing assessment of the effectiveness of the rating schedule and give advice on the most appropriate means of responding to the needs of veterans relating to disability compensation. On June 1, the Committee will receive briefings about studies on compensation for Veterans with service-connected disabilities and other Veteran benefits programs. On the afternoon of June 1 and the morning of June 2, the Committee will break into subcommittees to prepare recommendations. In the afternoon of June 2, time will be allocated for receiving public comments. Public comments will be limited to three PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 minutes each. Individuals wishing to make oral statements before the Committee will be accommodated on a first-come, first-served basis. Individuals who speak are invited to submit 1–2 page summaries of their comments at the time of the meeting for inclusion in the official meeting record. The public may submit written statements for the Committee’s review to Ms. Ersie Farber, Designated Federal Officer, Department of Veterans Affairs, Veterans Benefits Administration (211A), 810 Vermont Avenue, NW., Washington, DC 20420. Any member of the public wishing to attend the meeting or seeking additional information should contact Ms. Farber at (202) 461– 9728 or Ersie.farber@va.gov. Dated: May 7, 2009. By Direction of the Secretary: E. Philip Riggin, Committee Management Officer. [FR Doc. E9–11212 Filed 5–13–09; 8:45 am] BILLING CODE 8320–01–P E:\FR\FM\14MYN1.SGM 14MYN1

Agencies

[Federal Register Volume 74, Number 92 (Thursday, May 14, 2009)]
[Notices]
[Pages 22807-22808]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11211]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Clinical Science Research and Development Service; Cooperative 
Studies Scientific Evaluation Committee; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under Public 
Law 92-463 (Federal Advisory Committee Act) that a meeting of the 
Clinical Science Research and Development Service Cooperative Studies 
Scientific Evaluation Committee will be held on June 26, 2009, at The 
Ritz-Carlton, 1150 22nd Street, NW., Washington, DC. The meeting is 
scheduled to begin at 8 a.m. and end at 4 p.m.
    The Committee advises the Chief Research and Development Officer 
through the Director of the Clinical Science Research and Development 
Service on the relevance and feasibility of proposed projects and the 
scientific validity and propriety of technical details, including 
protection of human subjects.
    The session will be open to the public for approximately 30 minutes 
at the start of the meeting for the discussion of administrative 
matters and the general status of the program. The remaining portion of 
the meeting will be closed to the public for the Committee's review, 
discussion and evaluation of research and development applications.
    During the closed portion of the meeting, discussions and 
recommendations will deal with qualifications of personnel conducting 
the studies, staff and consultant critiques of research proposals and 
similar documents and the medical records of patients who are study 
subjects, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy. As provided by section 10(d) 
of Public Law 92-463, as amended, closing portions of this meeting is 
in accordance with 5 U.S.C. 552b(c)(6) and (c)(9)(B).
    Those who plan to attend should contact Dr. Grant Huang, Deputy 
Director, Cooperative Studies Program (125), Department of Veterans 
Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, at (202) 461-
1700.

    Dated: May 6, 2009.


[[Page 22808]]


    By Direction of the Secretary:
E. Philip Riggin,
Committee Management Officer.
[FR Doc. E9-11211 Filed 5-13-09; 8:45 am]
BILLING CODE 8320-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.